Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
The individualized precision prostate biopsy strategy is developed in this study, which can be used to make optimal decisions when faced with low-risk PCa (PI-RADS score 2) patients.
Authors
- Dian Xia (ORCID: https://orcid.org/0000-0003-2161-7870)
- Yifan Ma (ORCID: https://orcid.org/0000-0002-9371-4365)
- Zhiyao Xu
- Shuhan Liu (ORCID: https://orcid.org/0000-0002-6627-4843)
- Zhiyong Zhang (ORCID: https://orcid.org/0000-0001-8202-9672)
- Tao Tao (ORCID: https://orcid.org/0009-0006-4157-2883)
- Cheng Chen (ORCID: https://orcid.org/0000-0001-9424-9365)
- Liang Yong (ORCID: https://orcid.org/0009-0004-0746-7997)
- Ming-Shuo Huang
Institutions
- Wannan Medical College (CN)
- University of Science and Technology of China (CN)
- Bengbu Medical College (CN)
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- The Prostate
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1002/pros.70116
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00